Application 065092
- Type
- ANDA
- Sponsor
- RANBAXY LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RANICLOR | CEFACLOR | TABLET, CHEWABLE;ORAL | EQ 125MG BASE | No | No |
| 002 | RANICLOR | CEFACLOR | TABLET, CHEWABLE;ORAL | EQ 187MG BASE | No | No |
| 003 | RANICLOR | CEFACLOR | TABLET, CHEWABLE;ORAL | EQ 250MG BASE | No | No |
| 004 | RANICLOR | CEFACLOR | TABLET, CHEWABLE;ORAL | EQ 375MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065092-001 | RANICLOR | CEFACLOR | EQ 125MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | ||
| A065092-002 | RANICLOR | CEFACLOR | EQ 187MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | ||
| A065092-003 | RANICLOR | CEFACLOR | EQ 250MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | ||
| A065092-004 | RANICLOR | CEFACLOR | EQ 375MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A065092-001 | RANICLOR | EQ 125MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A065092-002 | RANICLOR | EQ 187MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A065092-003 | RANICLOR | EQ 250MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A065092-004 | RANICLOR | EQ 375MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A065092-001 | RANICLOR | EQ 125MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A065092-002 | RANICLOR | EQ 187MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A065092-003 | RANICLOR | EQ 250MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A065092-004 | RANICLOR | EQ 375MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A065092-001 | RANICLOR | EQ 125MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A065092-002 | RANICLOR | EQ 187MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A065092-003 | RANICLOR | EQ 250MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A065092-004 | RANICLOR | EQ 375MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065092-001 | RANICLOR | EQ 125MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065092-002 | RANICLOR | EQ 187MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065092-003 | RANICLOR | EQ 250MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A065092-004 | RANICLOR | EQ 375MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A065092-001 | RANICLOR | EQ 125MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A065092-002 | RANICLOR | EQ 187MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A065092-003 | RANICLOR | EQ 250MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A065092-004 | RANICLOR | EQ 375MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A065092-001 | RANICLOR | EQ 125MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A065092-002 | RANICLOR | EQ 187MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A065092-003 | RANICLOR | EQ 250MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A065092-004 | RANICLOR | EQ 375MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A065092-001 | RANICLOR | EQ 125MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A065092-002 | RANICLOR | EQ 187MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A065092-003 | RANICLOR | EQ 250MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A065092-004 | RANICLOR | EQ 375MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A065092-001 | RANICLOR | EQ 125MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A065092-002 | RANICLOR | EQ 187MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A065092-003 | RANICLOR | EQ 250MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A065092-004 | RANICLOR | EQ 375MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A065092-001 | RANICLOR | EQ 125MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A065092-002 | RANICLOR | EQ 187MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A065092-003 | RANICLOR | EQ 250MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A065092-004 | RANICLOR | EQ 375MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A065092-001 | RANICLOR | EQ 125MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A065092-002 | RANICLOR | EQ 187MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A065092-003 | RANICLOR | EQ 250MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A065092-004 | RANICLOR | EQ 375MG BASE | TABLET, CHEWABLE / ORAL | 2003-12-22 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefaclor | CEFACLOR | Carlsbad Technology, Inc. | 2f61354e-bcb0-41aa-955f-51eabc11387b | 2025-05-01 | Warnings, Adverse reactions | CEFACLOR |
| Cefaclor | CEFACLOR | A-S Medication Solutions | d79a4b28-ef2b-4f0f-baec-002df7d06dd4 | 2024-01-31 | Warnings, Adverse reactions | CEFACLOR |
| Cefaclor | CEFACLOR | Azorian Pharma, LLC | 224af904-38f3-4210-a750-e21006db4c66 | 2022-11-01 | Warnings, Adverse reactions | CEFACLOR |
| Cefaclor | CEFACLOR | Teva Pharmaceuticals USA, Inc. | 0878bdc2-0410-4938-9890-96523aa81c2f | 2019-07-31 | Warnings, Adverse reactions | CEFACLOR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.